Is the treatment effect of trifluridine and tipiracil (Lancever) tablets good?

Trifluridine and tipiracil (Lonsurf) are oral medications used to treat patients with metastatic colorectal cancer. It consists of two active ingredients: trifluridine and tipiracil. Trifluridine is an anti-cancer drug that inhibits the replication of cancer cells, while tipiracil increases the concentration and duration of trifluridine in the body by blocking the activity of the enzyme that breaks down trifluridine in the body. This combined use can improve the efficacy of the drug.

Based on clinical trials and studies, trifluridine and tipiracil have shown some efficacy in the treatment of metastatic colorectal cancer. One of the key clinical trials is the TAS-102 clinical trial, in which trifluridine tipiracil was compared with placebo. The results showed that the average survival time of patients who received trifluridine and tipiracil was significantly longer than that of patients who received placebo. Additionally, trifluridine and tipiracil have been shown to reduce pain and improve quality of life in patients with metastatic colorectal cancer. However, this drug may also cause side effects such as nausea, vomiting, fatigue, and low platelet counts.

Although trifluridine and tipiracil have shown some efficacy in the treatment of metastatic colorectal cancer, each patient's situation is different. Treatment results may vary depending on the patient's specific condition, physical condition, and other factors. Therefore, before using trifluridine or tipiracil, it is important to have a detailed discussion with your doctor to understand the drug's efficacy, side effects, and risks, and to develop a personalized treatment plan based on your doctor's recommendations.